share_log

派林生物(000403.SZ):部分董监高及核心管理人员拟增持不低于500万元公司股份

Pacific Shuanglin Bio-pharmacy (000403.SZ): Some directors, supervisors, and core management personnel intend to increase their shareholding in the company by no less than 5 million yuan.

Gelonghui Finance ·  Dec 27, 2024 17:24

On December 27, Gelonghui reported that Pacific Shuanglin Bio-pharmacy (000403.SZ) announced that the company recently received a notification of a voluntary shareholding increase plan from some of its directors, supervisors, and core management personnel. Based on confidence in the company's future development prospects and a high recognition of the company's value, the plan aims to promote the healthy, stable, and long-term development of the company, protect the interests of the broad shareholders, and enhance investor confidence. The plan is to increase the company's shares using self-owned funds through the Shenzhen Securities Exchange trading system within 6 months from the announcement date (excluding periods when laws, regulations, and relevant business rules of the Shenzhen Stock Exchange do not permit increases), with a total increase amount of no less than 5 million yuan. This increase plan does not set a price range and will be implemented at an opportune time based on the company's stock price fluctuations and the overall trend of the Capital Markets.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment